These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 8914042)
21. Studies on potential involvement of protein kinase C in glomerular insensitivity to atrial natriuretic factor on low sodium intake. Kalinowski L; SzczepaĆska-Konkel M; Jankowski M; Angielski S Med Sci Monit; 2001; 7(4):628-34. PubMed ID: 11433187 [TBL] [Abstract][Full Text] [Related]
22. "cAMP-specific" phosphodiesterase contributes to cGMP degradation in cerebellar cells exposed to nitric oxide. Bellamy TC; Garthwaite J Mol Pharmacol; 2001 Jan; 59(1):54-61. PubMed ID: 11125024 [TBL] [Abstract][Full Text] [Related]
25. Renal response to acute neutral endopeptidase inhibition in mild and severe experimental heart failure. Chen HH; Schirger JA; Chau WL; Jougasaki M; Lisy O; Redfield MM; Barclay PT; Burnett JC Circulation; 1999 Dec; 100(24):2443-8. PubMed ID: 10595958 [TBL] [Abstract][Full Text] [Related]
26. Increased cGMP phosphodiesterase activity mediates renal resistance to ANP in rats with bile duct ligation. Ni XP; Safai M; Gardner DG; Humphreys MH Kidney Int; 2001 Apr; 59(4):1264-73. PubMed ID: 11260387 [TBL] [Abstract][Full Text] [Related]
27. Maturation of cGMP response to ANP by isolated glomeruli. Norling LL; Vaughan CA; Chevalier RL Am J Physiol; 1992 Jan; 262(1 Pt 2):F138-43. PubMed ID: 1310228 [TBL] [Abstract][Full Text] [Related]
28. Inhibition of endogenous nitric oxide synthesis activates particulate guanylyl cyclase in the rat renal glomeruli. Lewko B; Wendt U; Szczepanska-Konkel M; Stepinski J; Drewnowska K; Angielski S Kidney Int; 1997 Sep; 52(3):654-9. PubMed ID: 9291184 [TBL] [Abstract][Full Text] [Related]
29. Therapeutic actions of a new synthetic vasoactive and natriuretic peptide, dendroaspis natriuretic peptide, in experimental severe congestive heart failure. Lisy O; Lainchbury JG; Leskinen H; Burnett JC Hypertension; 2001 Apr; 37(4):1089-94. PubMed ID: 11304508 [TBL] [Abstract][Full Text] [Related]
30. Relaxation and potentiation of cGMP-mediated response by ibudilast in bovine tracheal smooth muscle. Nakahara T; Yunoki M; Moriuchi H; Mitani A; Sakamoto K; Ishii K Naunyn Schmiedebergs Arch Pharmacol; 2002 Sep; 366(3):262-9. PubMed ID: 12172709 [TBL] [Abstract][Full Text] [Related]
31. Isozymes of cyclic-3',5'-nucleotide phosphodiesterases in renal epithelial LLC-PK1 cells. Rassier ME; McIntyre SJ; Yamaki M; Takeda S; Lin JT; Dousa TP Kidney Int; 1992 Jan; 41(1):88-99. PubMed ID: 1343559 [TBL] [Abstract][Full Text] [Related]
32. Stimulation of cyclic GMP synthesis in human cultured glomerular cells by atrial natriuretic peptide. Ardaillou N; Nivez MP; Ardaillou R FEBS Lett; 1986 Aug; 204(2):177-82. PubMed ID: 3015677 [TBL] [Abstract][Full Text] [Related]
33. Potentiation by forskolin of both SNP- and ANP-stimulated cyclic GMP accumulation in porcine isolated palmar lateral vein. Wright IK; Amirchetty-Rao S; Kendall DA Br J Pharmacol; 1994 Aug; 112(4):1146-50. PubMed ID: 7524992 [TBL] [Abstract][Full Text] [Related]
34. Cardiovascular effects of a novel, potent and selective phosphodiesterase 5 inhibitor, DMPPO: in vitro and in vivo characterization. Delpy E; le Monnier de Gouville AC Br J Pharmacol; 1996 Jul; 118(6):1377-84. PubMed ID: 8832060 [TBL] [Abstract][Full Text] [Related]
35. Phosphodiesterase II, the cGMP-activatable cyclic nucleotide phosphodiesterase, regulates cyclic AMP metabolism in PC12 cells. Whalin ME; Scammell JG; Strada SJ; Thompson WJ Mol Pharmacol; 1991 Jun; 39(6):711-7. PubMed ID: 1646946 [TBL] [Abstract][Full Text] [Related]
36. Altered role of C-type natriuretic peptide-activated pGC-cGMP-PDE3-cAMP signaling in hyperthyroid beating rabbit atria. Wen JF; Quan HX; Zhou GH; Cho KW Regul Pept; 2007 Aug; 142(3):123-30. PubMed ID: 17531330 [TBL] [Abstract][Full Text] [Related]
37. Contribution of phosphodiesterase isoenzymes and cyclic nucleotide efflux to the regulation of cyclic GMP levels in aortic smooth muscle cells. Mercapide J; Santiago E; Alberdi E; Martinez-Irujo JJ Biochem Pharmacol; 1999 Nov; 58(10):1675-83. PubMed ID: 10535760 [TBL] [Abstract][Full Text] [Related]
38. [Effect of digoxin on atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and cyclic 3', 5'-guanosine monophosphate (cGMP) in patients with chronic congestive heart failure]. Kobusiak-Prokopowicz M; Swidnicka-Szuszkowska B; Mysiak A Pol Arch Med Wewn; 2001 Jun; 105(6):475-82. PubMed ID: 11865578 [TBL] [Abstract][Full Text] [Related]
39. The role of neutral endopeptidase in dogs with evolving congestive heart failure. Margulies KB; Barclay PL; Burnett JC Circulation; 1995 Apr; 91(7):2036-42. PubMed ID: 7895362 [TBL] [Abstract][Full Text] [Related]
40. Formation of reactive oxygen metabolites in glomeruli is suppressed by inhibition of cAMP phosphodiesterase isozyme type IV. Chini CC; Chini EN; Williams JM; Matousovic K; Dousa TP Kidney Int; 1994 Jul; 46(1):28-36. PubMed ID: 7933846 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]